China Resources Medical (Shantou) Industrial Investment Fund Partnership Enterprise (LP) managed by China Resources Capital Management Limited sign the share transfer agreement to acquire 31.25% stake in Dongying Tiandong Pharmaceutical Co., Ltd. from China Resources Capital Management Limited for CNY 307.1875 million on August 2, 2022. The deal is subject to China Resources Double-Crane Pharmaceutical Co.,Ltd. board approval. As of August 2, 2022 China Resources Double-Crane Pharmaceutical Co.,Ltd board approved the deal.